会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Use of HSA-producing cells
    • 使用HSA生产细胞
    • US08597909B2
    • 2013-12-03
    • US13062781
    • 2009-09-09
    • Lore FlorinRebecca BischoffJuergen FiederHitto KaufmannThomas Krieg
    • Lore FlorinRebecca BischoffJuergen FiederHitto KaufmannThomas Krieg
    • C12P21/06
    • C12N5/0037C12N2500/30C12N2502/99C12N2510/02
    • The present invention refers to the area of cell culture technology and relates to methods for multiplying/cloning cells, preferably cell lines, which are important to the production of biopharmaceuticals. The invention further relates to methods for manufacturing proteins and to the use of cells extracted and multiplied through single cell sorting and to media compositions that enable a multiplication of single cells. Through the use of albumin-producing, preferably HSA-producing, cells as feeder cells for the conditioning of medium or as host cells, the recloning efficiency and thereby the quantity of clones obtained can be significantly increased. A combination of these approaches is also possible. Through the use of albumin-producing, preferably HSA-producing, cells, an increase in the recloning efficiency can be achieved in serum-free and/or insulin-free medium as well, and in different cell types.
    • 本发明涉及细胞培养技术的领域,涉及对生物药物生产重要的细胞,优选细胞系的繁殖/克隆方法。 本发明还涉及用于制造蛋白质的方法以及使用通过单细胞分选提取和倍增的细胞以及能够使单细胞增殖的培养基组合物的方法。 通过使用生产白蛋白,优选产生HSA的细胞作为培养基或宿主细胞调节的饲养细胞,可以显着提高获得的克隆效率,从而获得克隆的量。 这些方法的组合也是可能的。 通过使用产生白蛋白,优选产生HSA的细胞,可以在无血清和/或不含胰岛素的培养基以及不同细胞类型中实现再生能力的提高。
    • 2. 发明申请
    • USE OF HSA-PRODUCING CELLS
    • 使用HSA生产细胞
    • US20110262967A1
    • 2011-10-27
    • US13062781
    • 2009-09-09
    • Lore FlorinRebecca BischoffJuergen FiederHitto KaufmannThomas Krieg
    • Lore FlorinRebecca BischoffJuergen FiederHitto KaufmannThomas Krieg
    • C12P21/00C12N5/071
    • C12N5/0037C12N2500/30C12N2502/99C12N2510/02
    • The present invention refers to the area of cell culture technology and relates to methods for multiplying/cloning cells, preferably cell lines, which are important to the production of biopharmaceuticals. The invention further relates to methods for manufacturing proteins and to the use of cells extracted and multiplied through single cell sorting and to media compositions that enable a multiplication of single cells. Through the use of albumin-producing, preferably HSA-producing, cells as feeder cells for the conditioning of medium or as host cells, the recloning efficiency and thereby the quantity of clones obtained can be significantly increased. A combination of these approaches is also possible. Through the use of albumin-producing, preferably HSA-producing, cells, an increase in the recloning efficiency can be achieved in serum-free and/or insulin-free medium as well, and in different cell types.
    • 本发明涉及细胞培养技术的领域,涉及对生物药物生产重要的细胞,优选细胞系的繁殖/克隆方法。 本发明还涉及用于制造蛋白质的方法以及使用通过单细胞分选提取和倍增的细胞以及能够使单细胞增殖的培养基组合物的方法。 通过使用生产白蛋白,优选产生HSA的细胞作为培养基或宿主细胞调节的饲养细胞,可以显着提高获得的克隆效率,从而获得克隆的量。 这些方法的组合也是可能的。 通过使用产生白蛋白,优选产生HSA的细胞,可以在无血清和/或不含胰岛素的培养基以及不同细胞类型中实现再生能力的提高。